The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cetuximab in first-line treatment of metastatic colorectal cancer in a real-life setting: Preliminary results of the EREBUS cohort.
Denis Smith
No relevant relationships to disclose
Magali Rouyer
No relevant relationships to disclose
Emmanuel Mitry
No relevant relationships to disclose
Alain Monnereau
No relevant relationships to disclose
Antonio Sa Cunha
No relevant relationships to disclose
Emmanuelle Bignon
No relevant relationships to disclose
Alise Le Monies
No relevant relationships to disclose
Jeremy Jove
No relevant relationships to disclose
P. Noize
No relevant relationships to disclose
Nicholas Moore
No relevant relationships to disclose
Annie Fourrier-R├ęglat
No relevant relationships to disclose